Old Web
English
Sign In
Acemap
>
authorDetail
>
Kim Matthews
Kim Matthews
Charles River Laboratories
Pharmacology
In vivo
Histone deacetylase
Hydroxamic acid
Biochemistry
3
Papers
65
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Development and characterization of a CNS-penetrant benzhydryl hydroxamic acid class IIa histone deacetylase inhibitor
2018
Bioorganic & Medicinal Chemistry Letters
Christopher A. Luckhurst
Omar Aziz
Vahri Beaumont
Roland W. Bürli
Perla Breccia
Michel Maillard
Alan Findlay Haughan
Marieke Lamers
Phil Leonard
Kim Matthews
Gilles Raphy
Andrew J. Stott
Ignacio Munoz-Sanjuan
Beth Thomas
Michael Wall
Grant Wishart
Dawn Yates
Celia Dominguez
Show All
Source
Cite
Save
Citations (12)
Metabolism and Pharmacokinetics of JM6 in Mice: JM6 Is Not a Prodrug for Ro-61-8048
2012
Drug Metabolism and Disposition
Maria Beconi
Dawn Yates
Kathryn Lyons
Kim Matthews
Steve Clifton
Tania Mead
Michael Prime
Dirk Winkler
Catherine O'Connell
Daryl Walter
Leticia Toledo Sherman
Ignacio Munoz-Sanjuan
Celia Dominguez
Show All
Source
Cite
Save
Citations (22)
Oral Administration of the Pimelic Diphenylamide HDAC Inhibitor HDACi 4b Is Unsuitable for Chronic Inhibition of HDAC Activity in the CNS In Vivo
2012
PLOS ONE
Maria Beconi
Omar Aziz
Kim Matthews
Lara Moumné
Catherine O'Connell
Dawn Yates
Steven Clifton
Hannah Pett
Julie Vann
Lynsey Crowley
Alan Findlay Haughan
Donna L. Smith
Ben Woodman
Gillian P. Bates
Fred Brookfield
Roland W. Bürli
George McAllister
Celia Dominguez
Ignacio Munoz-Sanjuan
Vahri Beaumont
Show All
Source
Cite
Save
Citations (31)
1